These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 18601762)

  • 1. Successful treatment of unilateral cryptorchid boys risking infertility with LH-RH analogue.
    Hadziselimovic F
    Int Braz J Urol; 2008; 34(3):319-26; discussion 327-8. PubMed ID: 18601762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with a luteinizing hormone-releasing hormone analogue after successful orchiopexy markedly improves the chance of fertility later in life.
    Hadziselimović F; Herzog B
    J Urol; 1997 Sep; 158(3 Pt 2):1193-5. PubMed ID: 9258170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testicular histology related to fertility outcome and postpubertal hormone status in cryptorchidism.
    Hadziselimovic F; Hoecht B
    Klin Padiatr; 2008; 220(5):302-7. PubMed ID: 18401814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of High Infertility Risk among Unilateral Cryptorchid Boys.
    Bilius V; Verkauskas G; Dasevicius D; Kazlauskas V; Malcius D; Hadziselimovic F
    Urol Int; 2015; 95(2):142-5. PubMed ID: 25662488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between adult dark spermatogonia and secretory capacity of Leydig cells in cryptorchidism.
    Zivkovic D; Bica DT; Hadziselimovic F
    BJU Int; 2007 Nov; 100(5):1147-9; discussion 1149. PubMed ID: 17662083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation between adult dark spermatogonia and other parameters of fertility potential in cryptorchid testes.
    Thorup J; Kvist K; Clasen-Linde E; Petersen BL; Cortes D
    J Urol; 2013 Oct; 190(4 Suppl):1566-71. PubMed ID: 23357211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effect of luteinizing hormone-releasing hormone analogue (buserelin) on cryptorchid testes.
    Hadziselimović F; Huff D; Duckett J; Herzog B; Elder J; Snyder H; Buser M
    J Urol; 1987 Oct; 138(4 Pt 2):1043-5. PubMed ID: 2888905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cryptorchidism with low doses of buserelin over a 6-months period.
    Hadziselimovic F; Huff D; Duckett J; Herzog B; Elder J; Snyder H; Buser M
    Eur J Pediatr; 1987; 146 Suppl 2():S56-8. PubMed ID: 2891526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal therapy for the subfertility of cryptorchidism.
    Huff DS; Snyder HM; Rusnack SL; Zderic SA; Carr MC; Canning DA
    Horm Res; 2001; 55(1):38-40. PubMed ID: 11423741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infertility in cryptorchidism is linked to the stage of germ cell development at orchidopexy.
    Hadziselimovic F; Hocht B; Herzog B; Buser MW
    Horm Res; 2007; 68(1):46-52. PubMed ID: 17356291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant gonadotropin-releasing hormone therapy before surgery may improve the fertility index in undescended testes: a prospective randomized trial.
    Schwentner C; Oswald J; Kreczy A; Lunacek A; Bartsch G; Deibl M; Radmayr C
    J Urol; 2005 Mar; 173(3):974-7. PubMed ID: 15711353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin may reduce the risk of germ cell loss in boys with cryptorchidism.
    Cortes D; Visfeldt J; Thorup JM
    Horm Res; 2001; 55(1):41-5. PubMed ID: 11423742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of hormonal treatment with beta-human chorionic gonadotropin for cryptorchidism on future fertility in rats.
    Yilmaz Ö; Akyol İ; Özyurt M; Ateş F; Soydan H; Malkoç E
    J Pediatr Urol; 2015 Apr; 11(2):92.e1-4. PubMed ID: 25819376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for cryptorchid boys risking sterility and results of long-term buserelin treatment after successful orchiopexy.
    Hadziselimovic F; Herzog B; Höcht B; Hecker E; Miescher E; Buser M
    Eur J Pediatr; 1987; 146 Suppl 2():S59-62. PubMed ID: 2891527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptorchidism: aspects of fertility and neoplasms. A study including data of 1,335 consecutive boys who underwent testicular biopsy simultaneously with surgery for cryptorchidism.
    Cortes D; Thorup JM; Visfeldt J
    Horm Res; 2001; 55(1):21-7. PubMed ID: 11423738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility Potential is Compromised in 20% to 25% of Boys with Nonsyndromic Cryptorchidism despite Orchiopexy within the First Year of Life.
    Hildorf S; Clasen-Linde E; Cortes D; Fossum M; Thorup J
    J Urol; 2020 Apr; 203(4):832-840. PubMed ID: 31642739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of mini-puberty for fertility in cryptorchidism.
    Hadziselimovic F; Zivkovic D; Bica DT; Emmons LR
    J Urol; 2005 Oct; 174(4 Pt 2):1536-9; discussion 1538-9. PubMed ID: 16148647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre- and postoperative status of gonadotropins (FSH and LH) and inhibin-B in relation to testicular histopathology at orchiopexy in infant boys with unilateral undescended testes.
    Thorup J; Clasen-Linde E; Thorup SC; Cortes D
    J Pediatr Urol; 2015 Feb; 11(1):25.e1-5. PubMed ID: 25267218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infertility despite surgery for cryptorchidism in childhood can be classified by patients with normal or elevated follicle-stimulating hormone and identified at orchidopexy.
    Cortes D; Thorup J; Lindenberg S; Visfeldt J
    BJU Int; 2003 May; 91(7):670-4. PubMed ID: 12699482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptorchidism: medical and surgical treatment in the 1st year of life.
    Canavese F; Cortese MG; Magro P; Lonati L; Teruzzi E; de Sanctis C; Lala R
    Pediatr Surg Int; 1998 Nov; 14(1-2):2-5. PubMed ID: 9880684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.